Drug intelligence / Profile preview

hyodeoxycholic acid + statin

Development stage
Discontinued
Lead developer
AtheroNova
Modality
Small Molecules
Administration
Oral
01

Overview

This is a **combination** of two agents: hyodeoxycholic acid, a secondary bile acid, and a statin, which refers to any drug from the statin class (HMG-CoA reductase inhibitors). Hyodeoxycholic acid is used occasionally for its choleretic and hepatoprotective properties, whereas statins are widely prescribed to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, thereby reducing synthesis of cholesterol in the liver. Although combination therapy of **bile acids** (usually ursodeoxycholic acid, not hyodeoxycholic acid) and statins has been studied for hypercholesterolemia, synergistic lipid-lowering effects and potential hepatoprotective effects have been mostly described for ursodeoxycholic acid + statin, not specifically for hyodeoxycholic acid. No specific products or approved drugs containing hyodeoxycholic acid + statin are documented in main drug databases, and no routine use of this specific combination is established clinically.

02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on hyodeoxycholic acid + statin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyodeoxycholic acid + statin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call